NCT03613259 2020-06-09
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
6 trialsNCT02139150 2019-09-17
Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy
Memorial Sloan Kettering Cancer Center
Phase NA Withdrawn
NCT00894101 2018-07-20
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
University of California, Irvine
Phase 2/3 Withdrawn
NCT01610544 2018-07-05
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT02241668 2016-02-26
Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT01018251 2015-12-15
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn